Literature DB >> 25664049

Risk factors related to persistent airflow obstruction in severe asthma in Chinese Han population.

Lanlan Zhang1, Wenjuan Yang1, Qiao Zhou2, Gang Wang3, Chuntao Liu1.   

Abstract

OBJECTIVE: To explore the significance of assessing persistent airway obstruction (PAO) in asthma patients by airway wall remodeling with bronchoscopy, high-resolution computed tomography (HRCT), and biological markers in the induced sputum and serum, exhaled nitric oxide (FENO), and lung function.
METHODS: The study was conducted in 119 patients with PAO and 125 patients with reversible airway obstruction (RAO). Endobronchial biopsy specimens were analyzed for airway smooth muscle (ASM) area, and reticular basement membrane (RBM) thickness. Airway thickness was also measured by HRCT scanning. Levels of matrix metalloproteases-9 (MMP-9), metalloproteinase 33 (ADAM33), and vascular endothelial growth factor (VEGF) were measured in the induced sputum and serum by enzyme linked immunosorbent assay. RESULT: PAO was associated with longer disease duration, absence of atopy and rhinitis, and larger ASM area (SMA%) (15.83%±2.32% [n=9] vs. 8.0%±1.68% [n=7], P=0.02), thicker RBM (16.27±2.32 μm [n=9] vs. 8.71±2.41 μm [n=7], P=0.042); No differences in any of the biomarker molecules measured in airway thickness in HRCT, sputum and blood individually between groups were found.
CONCLUSION: Severe asthma patients with longer disease duration and the absence of atopy and rhinitis are more likely to develop PAO in Chines Han population. PAO patients have increased ASM area and RBM thickness appear to be valuable in the evaluation of airway remodeling in asthma patients in Chinese Han population.

Entities:  

Keywords:  Bronchoscopy; high-resolution computed tomography (HRCT); persistent airway obstruction (PAO); reversible airway obstruction (RAO)

Year:  2014        PMID: 25664049      PMCID: PMC4307496     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

Review 1.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

2.  ATS guidelines for methacholine and exercise challenge testing.

Authors:  V Popa
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

3.  Airway structural alterations selectively associated with severe asthma.

Authors:  Laurent Benayoun; Anne Druilhe; Marie-Christine Dombret; Michel Aubier; Marina Pretolani
Journal:  Am J Respir Crit Care Med       Date:  2003-01-16       Impact factor: 21.405

4.  Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction.

Authors:  Marta Kaminska; Susan Foley; Karim Maghni; Claudine Storness-Bliss; Harvey Coxson; Heberto Ghezzo; Catherine Lemière; Ronald Olivenstein; Pierre Ernst; Qutayba Hamid; James Martin
Journal:  J Allergy Clin Immunol       Date:  2009-05-29       Impact factor: 10.793

5.  Physical determinants of bronchial mucosal folding.

Authors:  R K Lambert; S L Codd; M R Alley; R J Pack
Journal:  J Appl Physiol (1985)       Date:  1994-09

6.  Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio.

Authors:  G M Doherty; S V Kamath; F de Courcey; S N Christie; A Chisakuta; J D Lyons; L G Heaney; M Ennis; M D Shields
Journal:  Clin Exp Allergy       Date:  2005-09       Impact factor: 5.018

7.  Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up.

Authors:  J M Vonk; H Jongepier; C I M Panhuysen; J P Schouten; E R Bleecker; D S Postma
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139

8.  Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study.

Authors:  June H Lee; Tmirah Haselkorn; Larry Borish; Lawrence Rasouliyan; Bradley E Chipps; Sally E Wenzel
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

9.  Asthma severity and medical resource utilisation.

Authors:  L Antonicelli; C Bucca; M Neri; F De Benedetto; P Sabbatani; F Bonifazi; H G Eichler; Q Zhang; D D Yin
Journal:  Eur Respir J       Date:  2004-05       Impact factor: 16.671

10.  Smoking, longer disease duration and absence of rhinosinusitis are related to fixed airway obstruction in Koreans with severe asthma: findings from the COREA study.

Authors:  Taehoon Lee; Yoon Su Lee; Yun-Jeong Bae; Tae-Bum Kim; Seon Ok Kim; Sang-Heon Cho; Hee-Bom Moon; You Sook Cho
Journal:  Respir Res       Date:  2011-01-03
View more
  1 in total

Review 1.  Targeted Therapy for Severe Asthma: Identifying the Right Patients.

Authors:  Kathy Low; Philip G Bardin
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.